Aytu BioScience Valuation
| AYTU Stock | USD 1.62 0.02 1.25% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Aytu BioScience shows a prevailing Real Value of $2.46 per share. The current price of the firm is $1.62. Our model approximates the value of Aytu BioScience from analyzing the firm fundamentals such as Profit Margin of (0.20) %, current valuation of 6.41 M, and Return On Equity of -0.47 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Aytu BioScience's valuation include:
Price Book 0.334 | Enterprise Value 6.4 M | Enterprise Value Ebitda 0.8838 | Price Sales 0.123 | Forward PE 2.6998 |
Undervalued
Today
Please note that Aytu BioScience's price fluctuation is very risky at this time. Calculation of the real value of Aytu BioScience is based on 3 months time horizon. Increasing Aytu BioScience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Aytu BioScience's intrinsic value may or may not be the same as its current market price of 1.62, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.62 | Real 2.46 | Target 5.0 | Hype 1.59 |
The intrinsic value of Aytu BioScience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aytu BioScience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aytu BioScience helps investors to forecast how Aytu stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aytu BioScience more accurately as focusing exclusively on Aytu BioScience's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Aytu BioScience's intrinsic value based on its ongoing forecasts of Aytu BioScience's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Aytu BioScience's closest peers.
Aytu BioScience Cash |
|
Aytu Valuation Trend
Aytu BioScience's real value is important for investors to make better decisions and a more accurate overall view of Aytu BioScience's financial worth over time. Using both Aytu BioScience's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Aytu BioScience Total Value Analysis
Aytu BioScience is presently anticipated to have valuation of 6.41 M with market capitalization of 9.96 M, debt of 15.13 M, and cash on hands of 23.81 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Aytu BioScience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.41 M | 9.96 M | 15.13 M | 23.81 M |
Aytu BioScience Investor Information
About 34.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.33. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aytu BioScience recorded a loss per share of 1.7. The entity last dividend was issued on the 9th of December 2020. The firm had 1:20 split on the 6th of January 2023. Based on the measurements of operating efficiency obtained from Aytu BioScience's historical financial statements, Aytu BioScience is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Aytu BioScience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aytu BioScience has an asset utilization ratio of 68.59 percent. This implies that the Company is making $0.69 for each dollar of assets. An increasing asset utilization means that Aytu BioScience is more efficient with each dollar of assets it utilizes for everyday operations.Aytu BioScience Ownership Allocation
30% of Aytu BioScience outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change.Aytu BioScience Profitability Analysis
The company reported the previous year's revenue of 81 M. Net Loss for the year was (15.84 M) with profit before overhead, payroll, taxes, and interest of 66.63 M.About Aytu BioScience Valuation
The stock valuation mechanism determines Aytu BioScience's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aytu BioScience based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aytu BioScience. We calculate exposure to Aytu BioScience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aytu BioScience's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 54.6 M | 57.3 M | |
| Pretax Profit Margin | (0.17) | (108.48) | |
| Operating Profit Margin | (0.06) | (107.70) | |
| Net Loss | (0.20) | (94.67) | |
| Gross Profit Margin | 0.67 | 28.57 |
Aytu BioScience Growth Indicators
Investing in growth stocks can be very risky. If the company such as Aytu BioScience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 5.5 M | |
| Forward Price Earnings | 2.6998 |
Aytu BioScience Current Valuation Indicators
Aytu BioScience's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Aytu BioScience's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Aytu BioScience, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Aytu BioScience's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Aytu BioScience's worth.Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.